Endoscopy
Signal score, how each part rates
ActionabilityPrevalenceStakesEvidence strengthNovelty
See the full rubric →Declining Cost-Effectiveness of Gastric Cancer Screening Over a Decade: A Cohort Modelling Study.
Clinical takeawayNo change for individual practice: a model of Korea's national programme that supports periodic reassessment of mature screening programmes and evaluation of differentiated approaches.
What it foundThe incremental cost-utility ratio (ICUR) for biennial endoscopic gastric cancer screening in Korea increased from KRW 9.62 million/QALY (USD 7,694) in 2012 to KRW 48.62 million/QALY (USD 38,895) in 2022, with women showing a higher ICUR (KRW 84.37 million/QALY, USD 67,497) than men (KRW 28.20 million/QALY, USD 22,558).
ContextThis literature reports a declining cost-effectiveness of gastric cancer screening over a decade, as evidenced by cohort modelling studies.
No standard claimed for this paper
Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.
Nam KA … Park JM · Endoscopy · IF 11.8 · PubMed ↗